References
Anti-Psoriasis Drug Screening. Accessed 24/05/2019 [Online].
Available:https://www.mattek.com/application/anti-psoriasis-drug-screening/[Accessed].
MelanoDerm®. Accessed 9th August 2019.
Melanoma®. Accessed 9th august 2019 [Online]. Available:https://www.mattek.com/products/melanoma/[Accessed].
Psoriasis Like” model from ATERA Labs. Accessed 9th August 2019[Online]. Available:http://www.ateralabs.com;http://www.ateralabs.com/downloads/ATERA-PRODUCTS-web.pdf[Accessed].
Psoriasis®. Accessed 9th August 2019. [Online]. Available:https://www.mattek.com/products/psoriasis/[Accessed].
Routes for drug administration trought the skin. Assessed
17/05/2019 [Online]. Available:https://www.msdmanuals.com/home/drugs/administration-and-kinetics-of-drugs/drug-administration[Accessed].
ABACI, H., GUO, Z., DOUCET, Y., JACKÓW, J. & CHRISTIANO, A. 2017. Next
generation human skin constructs as advanced tools for drug development.Experimental Biology and Medicine, 242, 1657-1668.
ABD, E., YOUSEF, S. A., PASTORE, M. N., TELAPROLU, K., MOHAMMED, Y.
H., et al. 2016. Skin models for the testing of transdermal
drugs. Clin Pharmacol, 8, 163-176.
ABRAHAM, W. & DOWNING, D. T. 1989. Preparation of model membranes for
skin permeability studies using stratum corneum lipids. J Invest
Dermatol, 93, 809-13.
AGACHE, P. 2004. Metrology of the stratum corneum. Measuring the
skin: non-invasive investigations, physiology, normal constants.Springer, Berlin.
ALÉPÉE, N., GRANDIDIER, M.-H., TORNIER, C. & COTOVIO, J. 2015. An
integrated testing strategy for in vitro skin corrosion and irritation
assessment using SkinEthic™ Reconstructed Human Epidermis.Toxicology in Vitro, 29, 1779-1792.
ALÉPÉE, N., GRANDIDIER, M. H. & COTOVIO, J. 2014. Sub-categorisation of
skin corrosive chemicals by the EpiSkin™ reconstructed human epidermis
skin corrosion test method according to UN GHS: Revision of OECD Test
Guideline 431. Toxicology in Vitro, 28, 131-145.
ALKILANI, A. Z., MCCRUDDEN, M. T. & DONNELLY, R. F. 2015. Transdermal
Drug Delivery: Innovative Pharmaceutical Developments Based on
Disruption of the Barrier Properties of the stratum corneum.Pharmaceutics, 7, 438-70.
ALVAREZ-FIGUEROA, M. J., PESSOA-MAHANA, C. D., PALAVECINO-GONZÁLEZ, M.
E., MELLA-RAIPÁN, J., ESPINOSA-BUSTOS, C., et al. 2011.
Evaluation of the Membrane Permeability (PAMPA and Skin) of
Benzimidazoles with Potential Cannabinoid Activity and their Relation
with the Biopharmaceutics Classification System (BCS). AAPS
PharmSciTech, 12, 573-578.
AMELIAN, A., WASILEWSKA, K., MEGIAS, D. & WINNICKA, K. 2017.
Application of standard cell cultures and 3D in vitro tissue models as
an effective tool in drug design and development. Pharmacological
Reports, 69, 861-870.
AU - BENNY, P., AU - BADOWSKI, C., AU - LANE, E. B. & AU - RAGHUNATH,
M. 2016. Improving 2D and 3D Skin In Vitro Models Using Macromolecular
Crowding. JoVE , e53642.
BALÁZS, B., VIZSERÁLEK, G., BERKÓ, S., BUDAI-SZŰCS, M., KELEMEN,
A., et al. 2016. Investigation of the Efficacy of Transdermal
Penetration Enhancers Through the Use of Human Skin and a Skin Mimic
Artificial Membrane. Journal of Pharmaceutical Sciences,105, 1134-1140.
BARBER, E. D., TEETSEL, N. M., KOLBERG, K. F. & GUEST, D. 1992. A
comparative study of the rates of in vitro percutaneous absorption of
eight chemicals using rat and human skin. Fundamental and Applied
Toxicology, 19, 493-497.
BERBEN, P., BAUER-BRANDL, A., BRANDL, M., FALLER, B., FLATEN, G.
E., et al. 2018. Drug permeability profiling using cell-free
permeation tools: Overview and applications. European Journal of
Pharmaceutical Sciences, 119, 219-233.
BOCHEŃSKA, K., SMOLIŃSKA, E., MOSKOT, M., JAKÓBKIEWICZ-BANECKA, J. &
GABIG-CIMIŃSKA, M. 2017. Models in the Research Process of Psoriasis.International Journal of Molecular Sciences, 18, 2514.
BOND, J. R. & BARRY, B. W. 1988. Hairless Mouse Skin is Limited as a
Model for Assessing the Effects of Penetration Enhancers in Human Skin.Journal of Investigative Dermatology, 90, 810-813.
BONFERONI, M. C., RIVA, F., INVERNIZZI, A., DELLERA, E., SANDRI,
G., et al. 2018. Alpha tocopherol loaded chitosan oleate
nanoemulsions for wound healing. Evaluation on cell lines and ex vivo
human biopsies, and stabilization in spray dried Trojan microparticles.European Journal of Pharmaceutics and Biopharmaceutics,123, 31-41.
BOS, J. D. & MEINARDI, M. M. 2000. The 500 Dalton rule for the skin
penetration of chemical compounds and drugs. Exp Dermatol,9, 165-9.
BRAGAGNI, M., MENNINI, N., MAESTRELLI, F., CIRRI, M. & MURA, P. 2012.
Comparative study of liposomes, transfersomes and ethosomes as carriers
for improving topical delivery of celecoxib. Drug Delivery,19, 354-361.
BURNS, E. M., TOBER, K. L., RIGGENBACH, J. A., SCHICK, J. S., LAMPING,
K. N., et al. 2013. Preventative topical diclofenac treatment
differentially decreases tumor burden in male and female Skh-1 mice in a
model of UVB-induced cutaneous squamous cell carcinoma.Carcinogenesis, 34, 370-377.
CAL, K. 2006. How does the type of vehicle influence the in vitro skin
absorption and elimination kinetics of terpenes? Archives of
Dermatological Research, 297, 311-315.
CAMBIER, L., WEATHERSPOON, A., DEFAWEUX, V., BAGUT, E. T., HEINEN, M.
P., et al. 2014. Assessment of the cutaneous immune response
during Arthroderma benhamiae and A. vanbreuseghemii infection using an
experimental mouse model. Br J Dermatol, 170, 625-33.
CANTON, I., COLE, D. M., KEMP, E. H., WATSON, P. F., CHUNTHAPONG,
J., et al. 2010. Development of a 3D human in vitro skin
co-culture model for detecting irritants in real-time. Biotechnol
Bioeng, 106, 794-803.
CHEN, Y., WU, Q., ZHANG, Z., YUAN, L., LIU, X., et al. 2012.
Preparation of curcumin-loaded liposomes and evaluation of their skin
permeation and pharmacodynamics. Molecules, 17, 5972-87.
CHIRICOZZI, A., NOGRALES, K. E., JOHNSON-HUANG, L. M., FUENTES-DUCULAN,
J., CARDINALE, I., et al. 2014. IL-17 induces an expanded range
of downstream genes in reconstituted human epidermis model. PLoS
One, 9, e90284.
CHOWHAN, Z. T. & PRITCHARD, R. 1978. Effect of Surfactants on
Percutaneous Absorption of Naproxen I: Comparisons of Rabbit, Rat, and
Human Excised Skin. Journal of Pharmaceutical Sciences,67, 1272-1274.
CILURZO, F., MINGHETTI, P. & SINICO, C. 2007. Newborn pig skin as model
membrane in in vitro drug permeation studies: A technical note.AAPS PharmSciTech, 8, 97-100.
CLARES, B., CALPENA, A. C., PARRA, A., ABREGO, G., ALVARADO, H.,
et al. 2014. Nanoemulsions (NEs), liposomes (LPs) and solid lipid
nanoparticles (SLNs) for retinyl palmitate: effect on skin permeation.Int J Pharm, 473, 591-8.
COMMANDEUR, S., VAN DRONGELEN, V., DE GRUIJL, F. R. & EL GHALBZOURI, A.
2012. Epidermal growth factor receptor activation and inhibition in 3D
in vitro models of normal skin and human cutaneous squamous cell
carcinoma. Cancer Sci, 103, 2120-6.
CORICOVAC, D., DEHELEAN, C., MOACA, E.-A., PINZARU, I., BRATU, T.,
et al. 2018. Cutaneous Melanoma—A Long Road from Experimental Models
to Clinical Outcome: A Review. International Journal of Molecular
Sciences, 19, 1566.
COZZI, S.-J., LE, T. T., OGBOURNE, S. M., JAMES, C. & SUHRBIER, A.
2013. Effective treatment of squamous cell carcinomas with ingenol
mebutate gel in immunologically intact SKH1 mice. Archives of
dermatological research, 305, 79-83.
CROSS, S. E., MAGNUSSON, B. M., WINCKLE, G., ANISSIMOV, Y. & ROBERTS,
M. S. 2003. Determination of the effect of lipophilicity on the in vitro
permeability and tissue reservoir characteristics of topically applied
solutes in human skin layers. J Invest Dermatol, 120,759-64.
DAI, N.-T., CHANG, H.-I., WANG, Y.-W., FU, K.-Y., HUANG, T.-C., et
al. 2018a. Restoration of skin pigmentation after deep partial or
full-thickness burn injury. Advanced Drug Delivery Reviews,123, 155-164.
DAI, N. T., HUANG, W. S., CHANG, F. W., WEI, L. G., HUANG, T. C.,
et al. 2018b. Development of a Novel Pre-Vascularized Three-Dimensional
Skin Substitute Using Blood Plasma Gel. Cell Transplant,27, 1535-1547.
DAS, B., SEN, S. O., MAJI, R., NAYAK, A. K. & SEN, K. K. 2017.
Transferosomal gel for transdermal delivery of risperidone: Formulation
optimization and ex vivo permeation. Journal of Drug Delivery
Science and Technology, 38, 59-71.
DESMET, E., RAMADHAS, A., LAMBERT, J. & VAN GELE, M. 2017. In vitro
psoriasis models with focus on reconstructed skin models as promising
tools in psoriasis research. Experimental biology and medicine
(Maywood, N.J.), 242, 1158-1169.
DIAS, M., HADGRAFT, J. & LANE, M. E. 2007. Influence of
membrane–solvent–solute interactions on solute permeation in model
membranes. International Journal of Pharmaceutics, 336,108-114.
DOBRIČIĆ, V., MARKOVIĆ, B., NIKOLIC, K., SAVIĆ, V., VLADIMIROV,
S., et al. 2014. 17β-carboxamide steroids – in vitro prediction
of human skin permeability and retention using PAMPA technique.European Journal of Pharmaceutical Sciences, 52, 95-108.
DRAGICEVIC-CURIC, N., GRÄFE, S., GITTER, B., WINTER, S. & FAHR, A.
2010. Surface charged temoporfin-loaded flexible vesicles: In vitro skin
penetration studies and stability. International Journal of
Pharmaceutics, 384, 100-108.
DRAGICEVIC-CURIC, N., SCHEGLMANN, D., ALBRECHT, V. & FAHR, A. 2008.
Temoporfin-loaded invasomes: Development, characterization and in vitro
skin penetration studies. Journal of Controlled Release,127, 59-69.
DUBEY, V., MISHRA, D., DUTTA, T., NAHAR, M., SARAF, D. K., et al.2007. Dermal and transdermal delivery of an anti-psoriatic agent via
ethanolic liposomes. J Control Release, 123, 148-54.
EGAWA, M., NOMURA, J. & IWAKI, H. 2010. The evaluation of the amount of
cis- and trans-urocanic acid in the stratum corneum by Raman
spectroscopy. Photochem Photobiol Sci, 9, 730-3.
ELIAS, P. M., ARBISER, J., BROWN, B. E., ROSSITER, H., MAN, M.-Q.,
et al. 2008. Epidermal vascular endothelial growth factor production is
required for permeability barrier homeostasis, dermal angiogenesis, and
the development of epidermal hyperplasia: implications for the
pathogenesis of psoriasis. The American journal of pathology,173, 689-699.
ELMOSLEMANY, R. M., ABDALLAH, O. Y., EL-KHORDAGUI, L. K. & KHALAFALLAH,
N. M. 2012. Propylene Glycol Liposomes as a Topical Delivery System for
Miconazole Nitrate: Comparison with Conventional Liposomes. AAPS
PharmSciTech, 13, 723-731.
ENGELHART, K., EL HINDI, T., BIESALSKI, H. K. & PFITZNER, I. 2005. In
vitro reproduction of clinical hallmarks of eczematous dermatitis in
organotypic skin models. Arch Dermatol Res, 297, 1-9.
ENGESLAND, A., SKALKO-BASNET, N. & FLATEN, G. E. 2015. Phospholipid
vesicle-based permeation assay and EpiSkin(R) in assessment of drug
therapies destined for skin administration. J Pharm Sci,104, 1119-27.
ENGESLAND, A., ŠKALKO-BASNET, N. & FLATEN, G. E. 2016. In vitro models
to estimate drug penetration through the compromised stratum corneum
barrier. Drug Development and Industrial Pharmacy, 42,1742-1751.
ENGESLAND, A., SKAR, M., HANSEN, T., SKALKO-BASNET, N. & FLATEN, G. E.
2013. New applications of phospholipid vesicle-based permeation assay:
permeation model mimicking skin barrier. J Pharm Sci,102, 1588-600.
FALLER, B. 2008. Artificial membrane assays to assess permeability.Curr Drug Metab, 9, 886-92.
FAWAY, É., LAMBERT DE ROUVROIT, C. & POUMAY, Y. 2018. In vitro models
of dermatophyte infection to investigate epidermal barrier alterations.Experimental Dermatology, 27, 915-922.
FENTEM, J. H. 1999. Validation of in vitro Tests for Skin Corrosivity.Altex, 16, 150-153.
FENTEM, J. H. & BOTHAM, P. A. 2004. Update on the validation and
regulatory acceptance of alternative tests for skin corrosion and
irritation. Atla-Alternatives to Laboratory Animals, 32,683-688.
FILOCAMO, G., BRUNETTI, M., COLACECI, F., SASSO, R., TANORI, M.,
et al. 2016. MK-4101, a Potent Inhibitor of the Hedgehog Pathway, Is
Highly Active against Medulloblastoma and Basal Cell Carcinoma.Mol Cancer Ther, 15, 1177-89.
FLATEN, G. E., BUNJES, H., LUTHMAN, K. & BRANDL, M. 2006a. Drug
permeability across a phospholipid vesicle-based barrier 2.
Characterization of barrier structure, storage stability and stability
towards pH changes. Eur J Pharm Sci, 28, 336-43.
FLATEN, G. E., DHANIKULA, A. B., LUTHMAN, K. & BRANDL, M. 2006b. Drug
permeability across a phospholipid vesicle based barrier: a novel
approach for studying passive diffusion. Eur J Pharm Sci,27, 80-90.
FLATEN, G. E., PALAC, Z., ENGESLAND, A., FILIPOVIC-GRCIC, J., VANIC,
Z., et al. 2015. In vitro skin models as a tool in optimization
of drug formulation. Eur J Pharm Sci, 75, 10-24.
FORSTER, M., BOLZINGER, M. A., FESSI, H. & BRIANCON, S. 2009. Topical
delivery of cosmetics and drugs. Molecular aspects of percutaneous
absorption and delivery. Eur J Dermatol, 19, 309-23.
FOWLER, J. 2012. Understanding the Role of Natural Moisturizing Factor
in Skin Hydration. Practical dermatology .
FREDERIKSEN, M., STAPLETON, H. M., VORKAMP, K., WEBSTER, T. F., JENSEN,
N. M., et al. 2018. Dermal uptake and percutaneous penetration of
organophosphate esters in a human skin ex vivo model.Chemosphere, 197, 185-192.
GAUR, P. K., MISHRA, S. & PUROHIT, S. 2013. Solid Lipid Nanoparticles
of Guggul Lipid as Drug Carrier for Transdermal Drug Delivery.BioMed Research International, 2013, 10.
GILLET, A., LECOMTE, F., HUBERT, P., DUCAT, E., EVRARD, B., et
al. 2011. Skin penetration behaviour of liposomes as a function of
their composition. European Journal of Pharmaceutics and
Biopharmaceutics, 79, 43-53.
GOMES, M. J., MARTINS, S., FERREIRA, D., SEGUNDO, M. A. & REIS, S.
2014. Lipid nanoparticles for topical and transdermal application for
alopecia treatment: development, physicochemical characterization, and
in vitro release and penetration studies. Int J Nanomedicine,9, 1231-42.
GREEN, C. B., CHENG, G., CHANDRA, J., MUKHERJEE, P., GHANNOUM, M.
A., et al. 2004. RT-PCR detection of Candida albicans ALS gene
expression in the reconstituted human epithelium (RHE) model of oral
candidiasis and in model biofilms. Microbiology, 150,267-275.
GROEN, D., GOORIS, G. S., PONEC, M. & BOUWSTRA, J. A. 2008. Two new
methods for preparing a unique stratum corneum substitute. Biochim
Biophys Acta, 1778, 2421-9.
GROVES, R. W., MIZUTANI, H., KIEFFER, J. D. & KUPPER, T. S. 1995.
Inflammatory skin disease in transgenic mice that express high levels of
interleukin 1 alpha in basal epidermis. Proceedings of the
National Academy of Sciences, 92, 11874-11878.
HAQ, A., GOODYEAR, B., AMEEN, D., JOSHI, V. & MICHNIAK-KOHN, B. 2018.
Strat-M® synthetic membrane: Permeability comparison to human cadaver
skin. International Journal of Pharmaceutics, 547,432-437.
HATHOUT, R. M., WOODMAN, T. J., MANSOUR, S., MORTADA, N. D., GENEIDI, A.
S., et al. 2010. Microemulsion formulations for the transdermal
delivery of testosterone. European Journal of Pharmaceutical
Sciences, 40, 188-196.
HUET, F., SEVERINO-FREIRE, M., CHÉRET, J., GOUIN, O., PRANEUF, J.,
et al. 2018. Reconstructed human epidermis for in vitro studies on
atopic dermatitis: A review. Journal of Dermatological Science,89, 213-218.
HUGHES, M. F. & EDWARDS, B. C. 2010. In vitro dermal absorption of
pyrethroid pesticides in human and rat skin. Toxicol Appl
Pharmacol, 246, 29-37.
ITOH, T., XIA, J., MAGAVI, R., NISHIHATA, T. & RYTTING, J. H. 1990. Use
of shed snake skin as a model membrane for in vitro percutaneous
penetration studies: comparison with human skin. Pharm Res,7, 1042-7.
JUNYAPRASERT, V. B., SINGHSA, P., SUKSIRIWORAPONG, J. & CHANTASART, D.
2012. Physicochemical properties and skin permeation of Span 60/Tween 60
niosomes of ellagic acid. International Journal of Pharmaceutics,423, 303-311.
JUREK, I., GÓRAL, I., MIERZYŃSKA, Z., MONIUSZKO-SZAJWAJ, B. &
WOJCIECHOWSKI, K. 2019. Effect of synthetic surfactants and soapwort
(Saponaria officinalis L.) extract on skin-mimetic model lipid
monolayers. Biochimica et Biophysica Acta (BBA) - Biomembranes,1861, 556-564.
KANDAROVA, H., LIEBSCH, M., GENSCHOW, E., GERNER, I., TRAUE, D.,
et al. 2004. Optimisation of the EpiDerm test protocol for the upcoming
ECVAM validation study on in vitro skin irritation tests.Altex-Alternativen Zu Tierexperimenten, 21, 107-114.
KANDAROVA, H., LIEBSCH, M., GERNER, I., SCHMIDT, E., GENSCHOW, E.,
et al. 2005. The EpiDerm test protocol for the upcoming ECVAM
validation study on in vitro skin irritation tests–an assessment of
the performance of the optimised test. Altern Lab Anim,33, 351-67.
KANDAROVA, H., LIEBSCH, M., SCHMIDT, E., GENSCHOW, E., TRAUE, D.,
et al. 2006. Assessment of the skin irritation potential of chemicals
by using the SkinEthic reconstructed human epidermal model and the
common skin irritation protocol evaluated in the ECVAM skin irritation
validation study. Altern Lab Anim, 34, 393-406.
KANSY, M., SENNER, F. & GUBERNATOR, K. 1998. Physicochemical High
Throughput Screening: Parallel Artificial Membrane Permeation Assay in
the Description of Passive Absorption Processes. Journal of
Medicinal Chemistry, 41, 1007-1010.
KARADZOVSKA, D., BROOKS, J. D., MONTEIRO-RIVIERE, N. A. & RIVIERE, J.
E. 2013. Predicting skin permeability from complex vehicles.Advanced Drug Delivery Reviews, 65, 265-277.
KARADZOVSKA, D. & RIVIERE, J. E. 2013. Assessing vehicle effects on
skin absorption using artificial membrane assays. European Journal
of Pharmaceutical Sciences, 50, 569-576.
KLAR, A. S., ZIMOCH, J. & BIEDERMANN, T. 2017. Skin Tissue Engineering:
Application of Adipose-Derived Stem Cells. Biomed Res Int,2017, 9747010.
KLIGMAN, A. M. & CHRISTOPHERS, E. 1963. Preparation of isolated sheets
of human stratum corneum. Arch Dermatol, 88, 702-5.
KNUDSEN, N. Ø., RØNHOLT, S., SALTE, R. D., JORGENSEN, L., THORMANN,
T., et al. 2012. Calcipotriol delivery into the skin with
PEGylated liposomes. European Journal of Pharmaceutics and
Biopharmaceutics, 81, 532-539.
KOCH, L., DEIWICK, A., SCHLIE, S., MICHAEL, S., GRUENE, M., et
al. 2012. Skin tissue generation by laser cell printing.Biotechnol Bioeng, 109, 1855-63.
KÖLLMER, M., MOSSAHEBI, P., SACHAROW, E., GORISSEN, S., GRÄFE, N.,
et al. 2019. Investigation of the Compatibility of the Skin PAMPA Model
with Topical Formulation and Acceptor Media Additives Using Different
Assay Setups. AAPS PharmSciTech, 20, 89.
KUCHLER, S., HENKES, D., ECKL, K. M., ACKERMANN, K., PLENDL, J.,
et al. 2011. Hallmarks of atopic skin mimicked in vitro by means of a
skin disease model based on FLG knock-down. Altern Lab Anim,39, 471-80.
KUCHLER, S., STRUVER, K. & FRIESS, W. 2013. Reconstructed skin models
as emerging tools for drug absorption studies. Expert Opin Drug
Metab Toxicol, 9, 1255-63.
KUMPUGDEE-VOLLRATH, M., SUBONGKOT, T. & NGAWHIRUNPAT, T. 2013. Model
Membrane from Shed Snake Skins. International Journal of
Pharmacological and Pharmaceutical Sciences, 7, 669-676.
KUNDU-RAYCHAUDHURI, S., CHEN, Y. J., WULFF, H. & RAYCHAUDHURI, S. P.
2014. Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of
Kv1.3 is effective in the SCID mouse psoriasis–xenograft model.J Autoimmun, 55, 63-72.
LANE, P. W. 1972. Two New Mutations in Linkage Group XVI of the House
Mouse: Flaky tail and varitint-waddler-J. Journal of Heredity,63, 135-140.
LEE, S. H., JEONG, S. K. & AHN, S. K. 2006. An update of the defensive
barrier function of skin. Yonsei Med J, 47, 293-306.
LEE, V., SINGH, G., TRASATTI, J. P., BJORNSSON, C., XU, X., et
al. 2014. Design and fabrication of human skin by three-dimensional
bioprinting. Tissue Eng Part C Methods, 20, 473-84.
LI, L., FUKUNAGA-KALABIS, M. & HERLYN, M. 2011. The three-dimensional
human skin reconstruct model: a tool to study normal skin and melanoma
progression. J Vis Exp .
LOFTSSON, T., KONRÁDSDÓTTIR, F. & MÁSSON, M. 2006. Development and
evaluation of an artificial membrane for determination of drug
availability. International Journal of Pharmaceutics,326, 60-68.
LÖWA, A., JEVTIĆ, M., GORREJA, F. & HEDTRICH, S. 2018. Alternatives to
animal testing in basic and preclinical research of atopic dermatitis.Experimental Dermatology, 27, 476-483.
LUO, L., PATEL, A., SINKO, B., BELL, M., WIBAWA, J., et al. 2016.
A comparative study of the in vitro permeation of ibuprofen in mammalian
skin, the PAMPA model and silicone membrane. International Journal
of Pharmaceutics, 505, 14-19.
MA, M., DI, H.-J., ZHANG, H., YAO, J.-H., DONG, J., et al. 2017.
Development of phospholipid vesicle-based permeation assay models
capable of evaluating percutaneous penetration enhancing effect.Drug Development and Industrial Pharmacy, 43, 2055-2063.
MA, Y., KURTYKA, C. A., BOYAPALLE, S., SUNG, S.-S., LAWRENCE, H.,
et al. 2008. A small-molecule E2F inhibitor blocks growth in a melanoma
culture model. Cancer research, 68, 6292-6299.
MADISON, K. C. 2003. Barrier Function of the Skin: “La Raison d’Être”
of the Epidermis. Journal of Investigative Dermatology,121, 231-241.
MANCA, M. L., MANCONI, M., NACHER, A., CARBONE, C., VALENTI, D.,
et al. 2014. Development of novel diolein–niosomes for cutaneous
delivery of tretinoin: Influence of formulation and in vitro assessment.International Journal of Pharmaceutics, 477, 176-186.
MARCONI, A., QUADRI, M., SALTARI, A. & PINCELLI, C. 2018. Progress in
melanoma modelling in vitro. Exp Dermatol, 27, 578-586.
MAREPALLY, S., BOAKYE, C. H. A., SHAH, P. P., ETUKALA, J. R., VEMURI,
A., et al. 2013. Design, Synthesis of Novel Lipids as Chemical
Permeation Enhancers and Development of Nanoparticle System for
Transdermal Drug Delivery. PLOS ONE, 8, e82581.
MARIMUTHU, M., BENNET, D. & KIM, S. 2012. Self-assembled nanoparticles
of PLGA-conjugated glucosamine as a sustained transdermal drug delivery
vehicle. Polymer Journal, 45, 202.
MARKOVIC, B. D., VLADIMIROV, S. M., CUDINA, O. A., ODOVIC, J. V. &
KARLJIKOVIC-RAJIC, K. D. 2012. A PAMPA Assay as Fast Predictive Model of
Passive Human Skin Permeability of New Synthesized Corticosteroid C-21
Esters. Molecules, 17, 480-491.
MATSUDA, H., WATANABE, N., GEBA, G. P., SPERL, J., TSUDZUKI, M.,
et al. 1997. Development of atopic dermatitis-like skin lesion with IgE
hyperproduction in NC/Nga mice. International Immunology,9, 461-466.
MECKFESSEL, M. H. & BRANDT, S. 2014. The structure, function, and
importance of ceramides in skin and their use as therapeutic agents in
skin-care products. Journal of the American Academy of
Dermatology, 71, 177-184.
MENTON, D. N. & EISEN, A. Z. 1971. Structure and organization of
mammalian stratum corneum. Journal of Ultrastructure Research,35, 247-264.
MEYER, W., SCHONNAGEL, B. & FLEISCHER, L. G. 2006. A note on
integumental (1–>3)(1–>6)beta-D-glucan
permeation, using the porcine ear skin model. J Cosmet Dermatol,5, 130-4.
MIKI, R., ICHITSUKA, Y., YAMADA, T., KIMURA, S., EGAWA, Y., et
al. 2015. Development of a membrane impregnated with a
poly(dimethylsiloxane)/poly(ethylene glycol) copolymer for a
high-throughput screening of the permeability of drugs, cosmetics, and
other chemicals across the human skin. European Journal of
Pharmaceutical Sciences, 66, 41-49.
MIN, D., LEE, W., BAE, I. H., LEE, T. R., CROCE, P., et al. 2018.
Bioprinting of biomimetic skin containing melanocytes. Exp
Dermatol, 27, 453-459.
MIZUTANI, Y., MITSUTAKE, S., TSUJI, K., KIHARA, A. & IGARASHI, Y. 2009.
Ceramide biosynthesis in keratinocyte and its role in skin function.Biochimie, 91, 784-790.
MOHAPATRA, S., COPPOLA, D., RIKER, A. I. & PLEDGER, W. J. 2007.
Roscovitine inhibits differentiation and invasion in a three-dimensional
skin reconstruction model of metastatic melanoma. Mol Cancer Res,5, 145-51.
MOJUMDAR, E. H., GOORIS, G. S., GROEN, D., BARLOW, D. J., LAWRENCE, M.
J., et al. 2016. Stratum corneum lipid matrix: Location of acyl
ceramide and cholesterol in the unit cell of the long periodicity phase.Biochim Biophys Acta, 1858, 1926-34.
MONER, V., FERNÁNDEZ, E., CALPENA, A. C., GARCIA-HERRERA, A., CÓCERA,
M., et al. 2018. A lamellar body mimetic system for the treatment
of oxazolone-induced atopic dermatitis in hairless mice. Journal
of Dermatological Science, 90, 172-179.
MONFORT, A., SORIANO-NAVARRO, M., GARCÍA-VERDUGO, J. M. & IZETA, A.
2013. Production of human tissue-engineered skin trilayer on a
plasma-based hypodermis. Journal of Tissue Engineering and
Regenerative Medicine, 7, 479-490.
MONIAGA, C. S., EGAWA, G., KAWASAKI, H., HARA-CHIKUMA, M., HONDA,
T., et al. 2010. Flaky Tail Mouse Denotes Human Atopic Dermatitis
in the Steady State and by Topical Application with Dermatophagoides
pteronyssinus Extract. The American Journal of Pathology,176, 2385-2393.
NAGELREITER, C., RAFFEINER, S., GEYERHOFER, C., KLANG, V. & VALENTA, C.
2013. Influence of drug content, type of semi-solid vehicle and
rheological properties on the skin penetration of the model drug
fludrocortisone acetate. International Journal of Pharmaceutics,448, 305-312.
NAKANO, M. & PATEL, N. K. 1970. Release, Uptake, and Permeation
Behavior of Salicylic Acid in Ointment Bases. Journal of
Pharmaceutical Sciences, 59, 985-988.
NETZLAFF, F., LEHR, C. M., WERTZ, P. W. & SCHAEFER, U. F. 2005. The
human epidermis models EpiSkin, SkinEthic and EpiDerm: an evaluation of
morphology and their suitability for testing phototoxicity, irritancy,
corrosivity, and substance transport. Eur J Pharm Biopharm,60, 167-78.
NETZLAFF, F., SCHAEFER, U. F., LEHR, C. M., MEIERS, P., STAHL, J.,
et al. 2006. Comparison of bovine udder skin with human and porcine
skin in percutaneous permeation experiments. Altern Lab Anim,34, 499-513.
NG, K. W. & LAU, W. M. 2015. Skin Deep: The Basics of Human Skin
Structure and Drug Penetration. In: DRAGICEVIC, N. & MAIBACH, H.
I. (eds.) Percutaneous Penetration Enhancers Chemical Methods in
Penetration Enhancement: Drug Manipulation Strategies and Vehicle
Effects. Berlin Heidelberg: Springer.
OECD 2011. Test No. 156: Guidance notes on dermal absorption.
OECD 2015. Test No. 439: In Vitro Skin Irritation: Reconstructed
Human Epidermis Test Method .
OLIVEIRA, G., BEEZER, A. E., HADGRAFT, J. & LANE, M. E. 2010. Alcohol
enhanced permeation in model membranes. Part I. Thermodynamic and
kinetic analyses of membrane permeation. International Journal of
Pharmaceutics, 393, 61-67.
OLIVEIRA, G., BEEZER, A. E., HADGRAFT, J. & LANE, M. E. 2011. Alcohol
enhanced permeation in model membranes. Part II. Thermodynamic analysis
of membrane partitioning. International Journal of Pharmaceutics,420, 216-222.
OLIVEIRA, G., HADGRAFT, J. & LANE, M. E. 2012. The role of vehicle
interactions on permeation of an active through model membranes and
human skin. International Journal of Cosmetic Science,34, 536-545.
OTTAVIANI, G., MARTEL, S. & CARRUPT, P.-A. 2006. Parallel Artificial
Membrane Permeability Assay: A New Membrane for the Fast Prediction of
Passive Human Skin Permeability. Journal of Medicinal Chemistry,49, 3948-3954.
OVAERE, P., LIPPENS, S., VANDENABEELE, P. & DECLERCQ, W. 2009. The
emerging roles of serine protease cascades in the epidermis.Trends Biochem Sci, 34, 453-63.
PALAC, Z., ENGESLAND, A., FLATEN, G. E., SKALKO-BASNET, N.,
FILIPOVIC-GRCIC, J., et al. 2014. Liposomes for (trans)dermal
drug delivery: the skin-PVPA as a novel in vitro stratum corneum model
in formulation development. J Liposome Res, 24, 313-22.
PASSERON, T., NAMIKI, T., PASSERON, H. J., LE PAPE, E. & HEARING, V. J.
2009. Forskolin Protects Keratinocytes from UVB-Induced Apoptosis and
Increases DNA Repair Independent of its Effects on Melanogenesis.Journal of Investigative Dermatology, 129, 162-166.
PENDARIES, V., MALAISSE, J., PELLERIN, L., LE LAMER, M., NACHAT,
R., et al. 2014. Knockdown of filaggrin in a three-dimensional
reconstructed human epidermis impairs keratinocyte differentiation.J Invest Dermatol, 134, 2938-2946.
PONEC, M. 1992. In vitro cultured human skin cells as alternatives to
animals for skin irritancy screening. Int J Cosmet Sci,14, 245-64.
POPLE, P. V. & SINGH, K. K. 2011. Development and evaluation of
colloidal modified nanolipid carrier: Application to topical delivery of
tacrolimus. European Journal of Pharmaceutics and
Biopharmaceutics, 79, 82-94.
POUILLOT, A., DAYAN, N., POLLA, A. S., POLLA, L. L. & POLLA, B. S.
2008. The stratum corneum: a double paradox. J Cosmet Dermatol,7, 143-8.
PRAUSNITZ, M. R., ELIAS, P. M., FRANZ, T. J., SCHMUTH, M., TSAI, J.
C., et al. 2012. Skin barrier and transdermal drug delivery.In: BOLOGNIA, J., JORIZZO, J. L. & SCHAFFER, J. V. (eds.)Dermatology. Philadelphia: Elsevier Saunders.
PRAUSNITZ, M. R., MITRAGOTRI, S. & LANGER, R. 2004. Current status and
future potential of transdermal drug delivery. Nat Rev Drug
Discov, 3, 115-24.
RADEMACHER, F., SIMANSKI, M., GLÄSER, R. & HARDER, J. 2018. Skin
microbiota and human 3D skin models. Experimental Dermatology,27, 489-494.
RANDALL, M. J., JÜNGEL, A., RIMANN, M. & WUERTZ-KOZAK, K. 2018.
Advances in the Biofabrication of 3D Skin in vitro: Healthy and
Pathological Models. Frontiers in Bioengineering and
Biotechnology, 6.
RASHID, A., EDWARD, M. & RICHARDSON, M. D. 1995. Activity of
terbinafine on Trichophyton mentagrophytes in a human living skin
equivalent model. Medical Mycology, 33, 229-233.
RHEINWALD, J. G. 1989. Methods for clonal growth and serial
cultivation of normal human epidermal keratinocytes and mesothelial
cells, in Cell Growth and Division, IRL, Oxford.
RHEINWALD, J. G. & GREEN, H. 1975. Serial cultivation of strains of
human epidermal keratinocytes: the formation of keratinizing colonies
from single cells. Cell, 6, 331-43.
RHEINWALD, J. G. & GREEN, H. 1977. Epidermal growth factor and the
multiplication of cultured human epidermal keratinocytes. Nature,265, 421-424.
RIGG, P. C. & BARRY, B. W. 1990. Shed snake skin and hairless mouse
skin as model membranes for human skin during permeation studies.J Invest Dermatol, 94, 235-40.
ROUAUD-TINGUELY, P., BOUDIER, D., MARCHAND, L., BARRUCHE, V., BORDES,
S., et al. 2015. From the morphological to the transcriptomic
characterization of a compromised three-dimensional in vitro model
mimicking atopic dermatitis. Br J Dermatol, 173,1006-14.
RUELA, A. L. M., PERISSINATO, A. G., LINO, M. E. D. S., MUDRIK, P. S. &
PEREIRA, G. R. 2016. Evaluation of skin absorption of drugs from topical
and transdermal formulations. Brazilian Journal of Pharmaceutical
Sciences, 52, 527-544.
SAHLE, F. F., WOHLRAB, J. & NEUBERT, R. H. H. 2014. Controlled
penetration of ceramides into and across the stratum corneum using
various types of microemulsions and formulation associated toxicity
studies. European Journal of Pharmaceutics and Biopharmaceutics,86, 244-250.
SALTON, M., KASPRZAK, W. K., VOSS, T., SHAPIRO, B. A., POULIKAKOS, P.
I., et al. 2015. Inhibition of vemurafenib-resistant melanoma by
interference with pre-mRNA splicing. Nat Commun, 6,7103.
SARKIRI, M., FOX, S. C., FRATILA-APACHITEI, L. E. & ZADPOOR, A. A.
2019. Bioengineered Skin Intended for Skin Disease Modeling.International Journal of Molecular Sciences, 20, 1407.
SATPATHY, A., DATTA, P., WU, Y., AYAN, B., BAYRAM, E., et al.2018. Developments with 3D bioprinting for novel drug discovery.Expert Opinion on Drug Discovery, 13, 1115-1129.
SCHAEFER, U. F., HANSEN, S., SCHNEIDER, M., CONTRERAS, J. L. & LEHR, C.
M. 2008. Models for Skin Absorption and Skin Toxicity Testing.